Charles River Laboratories International, Inc.

CRLNYSEUSD
160.30 USD
1.44 (0.91%)AT CLOSE (11:59 AM EDT)
160.32
0.02 (0.01%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
160.32
0.02 (0.01%)
🔴Market: CLOSED
Open?$159.83
High?$163.42
Low?$155.56
Prev. Close?$158.86
Volume?588.6K
Avg. Volume?870.0K
VWAP?$159.68
Rel. Volume?0.68x
Bid / Ask
Bid?$153.00 × 100
Ask?$185.00 × 100
Spread?$32.00
Midpoint?$169.00
Valuation & Ratios
Market Cap?7.7B
Shares Out?48.2M
Float?48.7M
Float %?98.7%
P/E Ratio?N/A
P/B Ratio?2.63
EPS?-$3.83
Dividend?0.00%
Ex-Dividend?N/A

Shares of Charles River Laboratories International, Inc. (CRL) are trading at $160.30. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of May 22, 2026.

News
Profile
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Employees
19.7K
Market Cap
7.7B
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Listed
2000-06-23
Address
251 BALLARDVALE ST
WILMINGTON, MA 01887
Phone: 781-222-6000
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
61
Momentum?
65
Short Sent.?
59
Piotroski F-Score?2/9Weak
Altman Z-Score?2.69Safe
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.88%Elevated
Short Interest?3.3M
Days to Cover?4.5
Free Float48.7M
Avg Daily Volume738.3K
Settlement Date2026-04-30
Financial Health
Current Ratio?1.36Adequate
Quick Ratio?1.03Adequate
Cash Ratio?0.18Low
Debt/Equity?0.91Moderate
ValuationATTRACTIVELY VALUEDvs 5 peers + S&P 500
Score
87/100
P/E?
N/A
P/B?
Peers
83
S&P
62
2.63CHEAP
P/S?
Peers
83
S&P
68
1.92CHEAP
P/FCF?
Peers
50
S&P
37
26.0FAIR
EV/EBITDA?
Peers
83
S&P
63
12.8FAIR
EV/Sales?
Peers
83
S&P
67
2.53CHEAP
Returns & Efficiency
ROE?
Peers
17
S&P
10
-6.3%WEAK
ROA?
Peers
17
S&P
3
-2.4%WEAK
Cash Flow & Enterprise
FCF?$296.7M
Enterprise Value?$10.2B
Fundamentals ratios updated end of day